Guardant Health
GH
#1516
Rank
A$20.62 B
Marketcap
A$158.84
Share price
2.24%
Change (1 day)
181.16%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of September 2025 : -A$0.54 Billion

According to Guardant Health 's latest financial reports the company has -A$0.54 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-A$0.23 Billion-196.39%
2023-12-31$A$0.23 B163.37%
2022-12-31$A$88.43 M-90.06%
2021-12-31$A$0.88 B-49.53%
2020-12-31$A$1.76 B45.56%
2019-12-31$A$1.21 B62.54%
2018-12-31$A$0.74 B88.51%
2017-12-31$A$0.39 B257.53%
2016-12-31$A$0.11 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Natera
NTRA
A$1.88 B-453.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
A$3.18 B-697.69%๐Ÿ‡บ๐Ÿ‡ธ USA